Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 51.7% |
| Food and Beverage | $342.52 | 11 | 35.4% |
| Education | $124.21 | 3 | 12.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $621.13 | 3 | $0 (2019) |
| Onkos Surgical, Inc. | $153.12 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $23.88 | 1 | $0 (2019) |
| Eisai Inc. | $22.02 | 1 | $0 (2020) |
| Exelixis Inc. | $22.02 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $18.79 | 1 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $18.01 | 1 | $0 (2019) |
| Amgen Inc. | $17.20 | 1 | $0 (2019) |
| Global Blood Therapeutics, Inc. | $16.22 | 1 | $0 (2021) |
| Lilly USA, LLC | $14.83 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.83 | 1 | Lilly USA, LLC ($14.83) |
| 2021 | $41.43 | 3 | Global Blood Therapeutics, Inc. ($16.22) |
| 2020 | $40.81 | 2 | Eisai Inc. ($22.02) |
| 2019 | $756.36 | 7 | Incyte Corporation ($522.13) |
| 2018 | $14.30 | 1 | Seattle Genetics, Inc. ($14.30) |
| 2017 | $99.00 | 1 | Incyte Corporation ($99.00) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2023 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Oncology | ||||||
| 12/22/2021 | Global Blood Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.22 | General |
| 10/14/2021 | Seagen Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $13.29 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 02/14/2020 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $18.79 | General |
| 01/30/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.02 | General |
| Category: Oncology | ||||||
| 12/17/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Oncology | ||||||
| 10/24/2019 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Oncology | ||||||
| 10/03/2019 | Onkos Surgical, Inc. | — | Food and Beverage | Cash or cash equivalent | $153.12 | General |
| Category: ELEOS LIMB SALVAGE SYSTEM | ||||||
| 08/22/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Oncology | ||||||
| 03/27/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Oncology | ||||||
| 03/06/2019 | Incyte Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| 03/06/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: Hematology/Oncology | ||||||
| 11/27/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Oncology | ||||||
| 08/18/2017 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 854 | 16,160 | $1.1M | $280,899 |
| 2022 | 45 | 1,265 | 22,688 | $1.7M | $344,482 |
| 2021 | 42 | 1,299 | 26,844 | $1.9M | $446,944 |
| 2020 | 45 | 1,413 | 40,744 | $2.8M | $682,932 |
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 3 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 28 | 50 | $7,850 | $1,200 | 15.3% |
| 96411 | Administration of additional new drug or substance into vein using push technique | Office | 2022 | 14 | 24 | $6,936 | $1,099 | 15.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 79 | 303 | $6,060 | $897.12 | 14.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 42 | 71 | $6,816 | $798.15 | 11.7% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 16 | 46 | $4,600 | $775.63 | 16.9% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 27 | 122 | $52,582 | $667.13 | 1.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 16 | 25 | $3,625 | $619.80 | 17.1% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 20 | 41 | $2,460 | $551.11 | 22.4% |
| J9267 | Injection, paclitaxel, 1 mg | Office | 2022 | 16 | 5,844 | $46,752 | $503.95 | 1.1% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2022 | 15 | 3,450 | $17,250 | $481.47 | 2.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2022 | 28 | 550 | $62,700 | $427.56 | 0.7% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2022 | 15 | 22 | $2,068 | $357.19 | 17.3% |
| 83550 | Iron binding capacity | Office | 2022 | 20 | 41 | $1,435 | $353.47 | 24.6% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2022 | 14 | 30 | $2,250 | $308.19 | 13.7% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2022 | 14 | 134 | $40,200 | $284.27 | 0.7% |
| J9190 | Injection, fluorouracil, 500 mg | Office | 2022 | 11 | 175 | $2,275 | $281.89 | 12.4% |
| 83540 | Iron level | Office | 2022 | 20 | 41 | $1,107 | $261.59 | 23.6% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2022 | 11 | 11 | $1,254 | $233.71 | 18.6% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 15 | 27 | $918.00 | $172.30 | 18.8% |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Office | 2022 | 31 | 620 | $14,880 | $169.35 | 1.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 64 | 1,223 | $1,223 | $111.90 | 9.1% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2022 | 15 | 27 | $594.00 | $101.12 | 17.0% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2022 | 33 | 70 | $490.00 | $55.25 | 11.3% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2022 | 18 | 23 | $437.00 | $49.08 | 11.2% |
| J3490 | Unclassified drugs | Office | 2022 | 25 | 45 | $360.00 | $24.10 | 6.7% |
About Dr. Vinh Trang, M.D
Dr. Vinh Trang, M.D is a Hematology & Oncology healthcare provider based in Olympia, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1477810612.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vinh Trang, M.D has received a total of $966.73 in payments from pharmaceutical and medical device companies, with $14.83 received in 2023. These payments were reported across 15 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($500.00).
As a Medicare-enrolled provider, Trang has provided services to 4,831 Medicare beneficiaries, totaling 106,436 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Olympia, WA
- Active Since 04/12/2012
- Last Updated 09/03/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477810612
Products in Payments
- ADCETRIS (Biological) $27.59
- LYNPARZA (Drug) $23.88
- JAKAFI (Drug) $22.13
- Cabometyx (Drug) $22.02
- Lenvima (Drug) $22.02
- Xofigo (Drug) $18.01
- XGEVA (Biological) $17.20
- VERZENIO (Drug) $14.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Olympia
Min Kang, Md, MD
Hematology & Oncology — Payments: $18,182
Ahmad Fora, Md, MD
Hematology & Oncology — Payments: $12,047
Dr. Shanthi Srinivas, M.d, M.D
Hematology & Oncology — Payments: $6,466
Dr. Jennifer Dacus, Md, MD
Hematology & Oncology — Payments: $457.61
Monique Semien, Md, MD
Hematology & Oncology — Payments: $70.37